Survival disparities among African American women with invasive bladder cancer in Florida

Cancer

Volumn 115, Issue 18, 2009, Pages 4196-4209

  Brookfield, Kathleen F ^a   Cheung, Michael C ^a   Gomez, Christopher ^a   Yang, Relin ^a   Nieder, Alan M ^a   Lee, David J ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Bladder cancer; Race; Socioeconomic status

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; ENDOSCOPIC SURGERY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; POVERTY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; SURVIVAL TIME; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; COMORBIDITY; FEMALE; FLORIDA; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; MINORITY HEALTH; POVERTY; PROGNOSIS; REGISTRIES; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 70149118974     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24497     Document Type: Article

References (45)

1. Henschke UK, Leffall LD Jr, Mason CH, et al. Alarming increase of the cancer mortality in the U.S. black population (1950-1967). Cancer. 1973;31:763-768.
2. Surveillance, Epidemiology and End Results (SEER) Program. Bethesda, MD: National Cancer Institute; 2005.
3. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37:583-587. (Pubitemid 24006624)
4. Chang SW, Kerlikowske K, Napoles-Springer A, et al. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996;78:1395-1402. (Pubitemid 26317859)
5. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
6. Hegarty V, Burchett BM, Gold DT, Cohen HJ. Racial differences in use of cancer prevention services among older Americans. J Am Geriatr Soc. 2000;48:735-740. (Pubitemid 30457409)
7. Liu WL, Kasl S, Flannery JT, et al. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control. 1995;6:425-430.
8. McCarthy BD, Yood MU, Boohaker EA, et al. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996;12:282-288.
9. Optenberg SA, Thompson IM, Friedrichs P, et al. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274:1599-1605.
10. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357. (Pubitemid 34257478)
11. Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican- American women. J Natl Cancer Inst Monogr. 1995;(18):41-47.
12. Sung HY, Kearney KA, Miller M, et al. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000;88:2283-2289. (Pubitemid 30247128)
13. Lee CT, Dunn RL, Williams C, Underwood W III. Racial disparity in bladder cancer: trends in tumor presentation at diagnosis. J Urol. 2006;176:927-933; discussion 933-934. (Pubitemid 43112488)
14. Prout GR Jr, Wesley MN, Greenberg RS, et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer. 2000;89:1349-1358.
15. Underwood W III, Dunn RL, Williams C, Lee CT. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg. 2006;202:284-290. (Pubitemid 43112488)
16. Watson RA, Sidor M. Bladder cancer in Native Americans and Alaskan Natives. Urology. 2008;72:10-14.
17. Zell JA, Cinar P, Mobasher M, et al. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26:66-75.
18. DeNavas-Walt C, Proctor BD, Smith J. Income, Poverty, and Health Insurance Coverage in the United States: 2006. Washington, DC: U.S. Census Bureau; 2006.
19. Brooks SE, Baquet CR, Gardner JF, et al. Cervical cancer - the impact of clinical presentation, health and race on survival. J Assoc Acad Minor Phys. 2000;11:55-59.
20. del Carmen MG, Montz FJ, Bristow RE, et al. Ethnic differences in patterns of care of stage 1A and stage 1A cervical cancer: a SEER database study. Gynecol Oncol. 1999;75:113-117.
21. Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 1999;94:509-515. (Pubitemid 29460931)
22. Jones WB, Shingleton HM, Russell A, et al. Patterns of care for invasive cervical cancer. Results of a national survey of 1984 and 1990. Cancer. 1995;76(10 suppl):1934-1947.
23. Leath CA III, Straughn JM Jr, Kirby TO, et al. Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol. 2005;99:432-436. (Pubitemid 41502857)
24. Mandelblatt J, Andrews H, Kerner J, et al. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health. 1991;81:646-649.
25. Mitchell JB, McCormack LA. Time trends in late-stage diagnosis of cervical cancer. Differences by race/ethnicity and income. Med Care. 1997;35:1220-1224.
26. Eifel PJ, Moughan J, Owen J, et al. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study. Int J Radiat Oncol Biol Phys. 1999;43:351-358. (Pubitemid 29091476)
27. Mundt AJ, Connell PP, Campbell T, et al. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 1998;71:151-158. (Pubitemid 28550794)
28. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008.
29. Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG. Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer. 2009;115:166-178.
30. Molina MA, Cheung MC, Perez EA, et al. African American and poor patients carry a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer. 2008;113:2797-2806.
31. DeNavas-Walt C, Proctor B, Mills R. Current Population Reports. Washington, DC: US Census Bureau; 2007:P60-P226.
32. Nieder AM, Mackinnon JA, Huang Y, et al. Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease. J Urol. 2008;179:491-495; discussion 495.
33. Mansson A, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer - influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol. 1993;27:363-369. (Pubitemid 23312264)
34. Mommsen S, Aagaard J, Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol. 1983;17:163-167.
35. Special Report on Cancer in the Economically Disadvantaged. Atlanta, GA: American Cancer Society; 1986.
36. Cancer in the Poor: A Report to the Nation. Atlanta, GA: American Cancer Society; 1989.
37. Byers T, Mouchawar J, Marks J, et al. The American Cancer Society challenge goals. How far can cancer rates decline in the US by the year 2015? Cancer. 1999;86:715-727.
38. Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol. 2009;16:3-13.
39. Gutierrez JC, Hurley JD, Housri N, et al. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients. Ann Surg. 2008;248:154-162.
40. Cheung MC, Perez EA, Molina MA, et al. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg. 2008;12:731-738.
41. Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245:952-958.
42. Hodgson N, Koniaris LG, Livingstone AS, Franceschi D. Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc. 2005;19:1610-1612. (Pubitemid 41719529)
43. Perez EA, Gutierrez JC, Jin X, et al. Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination. J Gastrointest Surg. 2007;11:114-125.
44. Perez EA, Koniaris LG, Snell SE, et al. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg. 2007;31:1022-1030.
45. Perez EA, Livingstone AS, Franceschi D, et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg. 2006;202:623-629.